Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2020 Jan-Dec:29:963689720920830.
doi: 10.1177/0963689720920830.

Cardiovascular Changes Associated with Hypertensive Heart Disease and Aging

Sherin Saheera  1 , Prasanna Krishnamurthy  2
Affiliations
Review

Cardiovascular Changes Associated with Hypertensive Heart Disease and Aging

Sherin Saheera et al. Cell Transplant. 2020 Jan-Dec.

Abstract

Cardiovascular diseases are the leading cause of mortality and morbidity worldwide and account for more than 17.9 million deaths (World Health Organization report). Hypertension and aging are two major risk factors for the development of cardiac structural and functional abnormalities. Hypertension, or elevated blood pressure, if left untreated can result in myocardial hypertrophy leading to heart failure (HF). Left ventricular hypertrophy consequent to pressure overload is recognized as the most important predictor of congestive HF and sudden death. The pathological changes occurring during hypertensive heart disease are very complex and involve many cellular and molecular alterations. In contrast, the cardiac changes that occur with aging are a slow but life-long process and involve all of the structural components in the heart and vasculature. However, these structural changes in the cardiovascular system lead to alterations in overall cardiac physiology and function. The pace at which these pathophysiological changes occur varies between individuals owing to many genetic and environmental risk factors. This review highlights the molecular mechanisms of cardiac structural and functional alterations associated with hypertension and aging.

Keywords: aging; cardiac hypertrophy; heart failure; hypertension.

PubMed Disclaimer

Conflict of interest statement

Declaration of Conflicting Interests: The author(s) declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.

Figures

Fig. 1.
Fig. 1.
The differences and similarities of the cardiovascular changes associated with hypertensive heart disease and aging. CSC: cardiac stem cell
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Slivnick J, Lampert BC. Hypertension and heart failure. Heart Fail Clin. 2019;15(4):531–541. - PubMed
    1. Meijs MFL, de Windt LJ, de Jonge N, Cramer M-JM, Bots ML, Mali WPTM, Doevendans PA. Left ventricular hypertrophy: a shift in paradigm. Curr Med Chem. 2007;14(2):157–171. - PubMed
    1. Ahmad F, Singh AP, Tomar D, Rahmani M, Zhang Q, Woodgett JR, Tilley DG, Lal H, Force T. Cardiomyocyte-GSK-3α promotes mPTP opening and heart failure in mice with chronic pressure overload. J Mol Cell Cardiol. 2019;130(18):65–75. - PMC - PubMed
    1. Liu J, Zhuang T, Pi J, Chen X, Zhang Q, Li Y, Wang H, Shen Y, Tomlinson B, Chan P, Yu Z, et al. Endothelial forkhead box transcription factor p1 regulates pathological cardiac remodeling through transforming growth factor-β1-endothelin-1 signal pathway. Circulation. 2019;140(8):665–680. - PubMed
    1. Santos M, Shah AM. Alterations in cardiac structure and function in hypertension. Curr Hypertens Rep. 2014;16(5):428. - PMC - PubMed

Publication types

MeSH terms